Shanghai Pharma bids for U.S. Cardinal Health's China business

HONG KONG (Reuters) - Shanghai Pharmaceuticals Holding Co has bid for Cardinal Health Inc's China business as the U.S. company looks to sell ahead of China's planned drug distribution reform.